Instadose Pharma Corp.
OTC: INSD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Antonio Rocco Franchino
- Employees
- 2
- Headquarters
- Chesapeake, United States
- IPO year
- 2020
- Market cap
- $53.2K
- Website
- https://www.instadosepharma.com
Loading INSD…
Loading profile data…Frequently asked questions about INSD
What does Instadose Pharma Corp. (INSD) do?
Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.
Where does INSD trade?
Instadose Pharma Corp. (INSD) trades on the Other OTC.
What sector is INSD in?
Instadose Pharma Corp. (INSD) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Instadose Pharma Corp.?
Antonio Rocco Franchino is the chief executive officer of Instadose Pharma Corp. (INSD).
Where is Instadose Pharma Corp. headquartered?
Instadose Pharma Corp. is headquartered in United States.
Does INSD pay a dividend?
Instadose Pharma Corp. (INSD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INSD go public?
Instadose Pharma Corp. (INSD) completed its initial public offering in 2020.